User profiles for Tsuyoshi Shirai

Tsuyoshi Shirai

Nagahama Institute of Bioscience and Technology
Verified email at nagahama-i-bio.ac.jp
Cited by 2860

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

T Shirai, RR Nazarewicz, BB Wallis… - Journal of Experimental …, 2016 - rupress.org
Abnormal glucose metabolism and enhanced oxidative stress accelerate cardiovascular
disease, a chronic inflammatory condition causing high morbidity and mortality. Here, we report …

[PDF][PDF] Aicardi-Goutieres syndrome is caused by IFIH1 mutations

…, Y Sugawara, T Yasumi, H Kato, T Shirai… - The American Journal of …, 2014 - cell.com
Aicardi-Goutières syndrome (AGS) is a rare, genetically determined early-onset progressive
encephalopathy. To date, mutations in six genes have been identified as etiologic for AGS. …

[PDF][PDF] Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

…, W Saso, K Shionoya, S Iwanami, T Hirokawa, T Shirai… - Iscience, 2021 - cell.com
Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We
screened a panel of already approved drugs in a cell culture model of severe acute respiratory …

Macrophages in vascular inflammation–from atherosclerosis to vasculitis

T Shirai, M Hilhorst, DG Harrison, JJ Goronzy… - …, 2015 - Taylor & Francis
The spectrum of vascular inflammatory disease ranges from atherosclerosis and hypertension,
widespread conditions affecting large proportions of the population, to the vasculitides, …

[HTML][HTML] NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs

Z Wen, Y Shimojima, T Shirai, Y Li, J Ju… - The Journal of …, 2016 - Am Soc Clin Investig
Immune aging results in progressive loss of both protective immunity and T cell–mediated
suppression, thereby conferring susceptibility to a combination of immunodeficiency and …

Identification of a High‐Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell–Based Phenotype Dissection

…, A Watanabe, S Nishimata, T Shirai… - Arthritis & …, 2017 - Wiley Online Library
Objective To elucidate the genetic background of a patient with neonatal‐onset multisystem
inflammatory disease (NOMID) with no NLRP3 mutation. Methods A Japanese male child …

High-resolution crystal structure of M-protease: phylogeny aided analysis of the high-alkaline adaptation mechanism.

T Shirai, A Suzuki, T Yamane, T Ashida… - Protein …, 1997 - academic.oup.com
M-protease is a subtilisin-family serine protease produced by an alkaliphilic Bacillus sp.
strain. Optimal enzymatic activity of the protein occurs at pH 12.3. The crystal structure of M-…

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

…, W Saso, K Shionoya, S Iwanami, T Hirokawa, T Shirai… - BioRxiv, 2020 - biorxiv.org
Antiviral treatments targeting the emerging coronavirus disease 2019 (COVID-19) are
urgently required. We screened a panel of already-approved drugs in a cell culture model of …

The influence of PRNP polymorphisms on human prion disease susceptibility: an update

A Kobayashi, K Teruya, Y Matsuura, T Shirai… - Acta …, 2015 - Springer
Two normally occurring polymorphisms of the human PRNP gene, methionine (M)/valine (V)
at codon 129 and glutamic acid (E)/lysine (K) at codon 219, can affect the susceptibility to …

[HTML][HTML] Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity

R Watanabe, T Shirai, H Namkoong… - The Journal of …, 2017 - Am Soc Clin Investig
Patients with coronary artery disease (CAD) are at high risk for reactivation of the varicella
zoster virus (VZV) and development of herpes zoster (HZ). Here, we found that macrophages …